CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

COMPOUNDS AND USES THEREOF

HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS

FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS

TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF

POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1

NOVEL COMPOUNDS AND USES THEREOF

METHODS OF TREATING INFLAMMATORY DISEASES

INTEGRATION OF MOLECULAR MECHANISMS IN THE STRIATUM AS A COMBINATION DRUG STRATEGY FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISORDERS IN WHICH ANHEDONIA OR MOTIVATION-RELATED DYSFUNCTION EXISTS

EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN COMBINATION WITH HGF-RECEPTOR INHIBITORS FOR THE TREATMENT OF CANCER

GCN2 INHIBITOR FOR TREATING METASTASES

N-methyl-D-aspartic Acid Receptor Modulators

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

IMIDAZOLYL-AMINO-PYRAZINE-CARBONITRILS AS CHK-1 INHIBITORS

Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4

COMPOUND FOR RECOVERING P53 MUTATION FUNCTION AND USE THEREOF

NOVEL SPIRO COMPOUND

MODIFYING EARLY-STAGE PARKINSON'S DISEASE PROGRESSION WITH DEEP BRAIN STIMULATION

EXTRUDED SOFT CHEW CONTAINING A NON-ANIMAL BASED PALATANT AND ACTIVE PHARMACEUTICAL INGREDIENTS

PALATABLE FORMULATIONS

LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF

5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS

INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF

INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS

PROTAC CHIMERIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

KIF MODULATOR COMPOUNDS AND METHODS OF USE

Tyrosine Kinase Inhibitors and Uses Thereof

PHARMACEUTICAL COMPOSITION

METHODS OF TREATING CENTERAL NERVOUS SYSTEM DISORDERS COMPRISING ADMINISTERING DEUTERATED LUMATEPERONE AND A NITRIC OXIDE DONOR

PAPD5 INHIBITORS AND METHODS OF USE THEREOF

PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF

2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS

5-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF

AZOLE DERIVATIVES AS SHP2 INHIBITORS

GIP RECEPTOR AGONIST COMPOUNDS

PYRAZOLYL INDAZOLE CGAS INHIBITORS AND USES THEREOF

6-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF

METHODS FOR REPROGRAMING EXHAUSTED T CELLS AND BOOSTING IMMUNE CHECKPOINT BLOCKADE THERAPY FOR CANCER

INHIBITING HISTONE DEACETYLASE 6

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

SYK ACTIVATORS AND INHIBITORS IN NEURODEGENERATIVE DISEASES

TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB

PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

NOVEL COMPOUNDS

Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof

GIP RECEPTOR AGONIST COMPOUNDS

AMORPHOUS SOLID DISPERSIONS

NOVEL COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY

NOVEL CRYSTALLINE FORM OF 1-(8-BROMOPYRIDO[2,3- E][1,2,4]TRIAZOLO[4,3-A]PYRAZIN-4-YL)-NMETHYLAZETIDIN- 3-AMINE

NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF

Combinations Comprising Psychedelics for the Treatment of Schizophrenia and Other Neuropsychiatric and Neurologic Disorders

UPADACITINIB FORMULATION

NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF

INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS

ISOQUINOLONES AS PI3K INHIBITORS

PYRAZOLE AND IMIDAZOLE DERIVATIVES AS DUAL OREXIN AND KAPPA-OPIOID RECEPTORS MODULATORS COMPOSITION, METHODS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS

SULFONYL DERIVATIVES AS CCR6 INHIBITORS

INHIBITORS OF KIF18A AND USES THEREOF

Composition and Method for Treating Metabolic Disorders

OVARIAN CANCER VACCINES

ENGAGING THE CERVICAL SPINAL CORD CIRCUITRY TO RE-ENABLE VOLITIONAL CONTROL OF HAND FUNCTION IN TETRAPLEGIC SUBJECTS

TYK2 INHIBITORS AND USES THEREOF

INDANE AND COUMARAN DERIVATIVES AS FAST SKELETAL MUSCLE MYOSIN INHIBITORS

OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF

METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION

NOVEL METHODS

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

AMIDO PYRIDO[3,4-B]INDOLE-1,4-DIONE COMPOUNDS FOR TREATMENT OF PORPHYRIAS

WILD TYPE KIT INHIBITORS

SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF PSYCHOSIS AND PSYCHOTIC DISORDERS

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

USE OF CO-PROCESSED EXCIPIENTS IN CONTINUOUS MANUFACTURING OF SOLID DOSAGE FORMS

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY

ORGANIC COMPOUNDS

GEPOTIDACIN FORMULATION

COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

PKC-Theta Modulators

N-PHENYL-1-(PHENYLSULFONYL)PIPERIDIN-4-AMINE DERIVATIVES AS CCR6 INHIBITORS

NOVEL SALTS AND CRYSTALS

CDK2 INHIBITORS AND METHODS OF USING THE SAME

TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

Substituted Imidazopyrazine Compounds as Ligand Directed Degraders of IRAK3

N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER

HETEROARYL DERIVATIVES AS DDRs INHIBITORS

Compositions for Modulating Lipoxygenase and Methods of Using Same

PHARMACEUTICAL COMPOSITION OF HETEROARYL DERIVATIVE AND MEDICAL USE THEREOF

Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer

MATERIALS AND METHODS FOR THE MANUFACTURE OF AN ANIMAL FEED

HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS

METHODS FOR TREATING ALZHEIMER DISEASE AND FOR REDUCING AMYLOID BETA FORMATION

PHARMACEUTICAL COMPOSITIONS

SMALL MOLECULE BROAD-SPECTRUM ANTIBIOTICS

BIARYL DERIVATIVES AND RELATED USES

Solid State Forms of Ensifentrine

COMBINATION THERAPY FOR PI3K-ASSOCIATED DISEASE OR DISORDER

REHYDRATION COMPOSITION AND METHOD OF USE

Uses of JAK Inhibitors in the Management of Inflammation-Associated Depression and Central Nervous System (CNS) Pathologies

DEVELOPMENT OF ALPHA-1A-ADRENERGIC RECEPTOR AGONISTS AS A THERAPY TO TREAT HEART FAILURE

TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A JAK OR OTHER KINASE INHIBITOR

STAT6 DEGRADERS

BIOMARKERS OF PREGNANCY LOSS

SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES

CBL-B INHIBITORS AND METHODS OF USES THEREOF

COMPOSITIONS COMPRISING TIGOLANER FOR CONTROLLING PARASITES

EXTENDED RELEASE UPADACITINIB FORMULATIONS

COMPOUND FOR REGULATING AND CONTROLLING ACTIVITY OF 15-PGDH AND PREPARATION METHOD THEREFOR

4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS

COMPOUNDS AS MYT1 INHIBITORS

Compounds and Their Use as PDE4 Activators

Compounds and Their Use as PDE4 Activators

ANTIMALARIAL COMPOUNDS

PRMT5 INHIBITORS AND USES THEREOF

COMPOUNDS AND METHOD FOR PKMYT1 INHIBITION

ORGANIC COMPOUNDS

NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE

ARSINOTHRICIN AND METHODS OF TREATING INFECTIONS USING ARSINOTHRICIN

Nanoparticle Compositions and Methods for Synthesis Thereof

HETEROCYCLIC COMPOUND AS TAAR1 LIGAND AGONIST

Anticancer polyheterocyclic compounds and associated methods

NITROGEN-CONTAINING COMPOUND AND USE THEREOF

INHIBITORS OF FGFR2 AND FGFR3 AND USES THEREOF

NITROGEN-CONTAINING FUSED THREE RING PRMT5 INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

CANCER TREATMENT AGENT INCLUDING MALT1 INHIBITING DRUG AS ACTIVE INGREDIENT

PRMTS INHIBITOR AND USE THEREOF

INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS

CBL-B INHIBITORS AND ANTI-PD1/ANTI-PD-L1 FOR USE IN THE TREATMENT OF CANCER

ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

TREATMENT OF MITOCHONDRIAL DISEASES WITH A CNS-PENETRANT SGC STIMULATOR ZAGOCIGUAT

PROTEIN DEGRADERS AND USES THEREOF

CSF-1R INHIBITORS AND USES THEREOF

NOVEL METHODS

Treatment or Reversal of Treatment Resistant Depression and Related Central Nervous System (CNS) Inflammatory Conditions with a JAK Inhibitor

TARGETING AN ENZYME REQUIRED FOR ACUTE MYELOID LEUKEMIA

METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2

INDAZOLE CONTAINING MACROCYCLES AND THEIR USE

C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER

COMPOUNDS AS CCR6 INHIBITORS

FLAVIVIRUS INHIBITORS

HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

BTK Reducing Molecules for Treatment of Cancers and Immune System Disorders

A BENZIMIDAZOLE COMPOUND WITH ANTIHELMINTHIC ACTIVITY FOR USE IN REVERSING, ARRESTING OR SLOWING DOWN CELLULAR AGEING IN A VERTEBRATE SUBJECT

NOVEL COMPOSITIONS, DEVICES, AND METHODS

BICYCLIC DERIVATIVE PARP INHIBITOR AND USE THEREOF

METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

HETEROCYCLIC COMPOUND CCR4 INHIBITOR AND USER THEREOF

COMPOSITIONS AND METHODS FOR USE IN KRAS-TARGETED THERAPIES FOR THE TREATMENT OF CANCER

AMORPHOUS SOLID DISPERSIONS

GCN2 MODULATOR FOR TREATING CANCER

SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS

COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING

PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO

PHARMACEUTICAL COMPOSITIONS OF NILOTINIB

METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS

REACTIVE OXYGEN SPECIES MODULATION THROUGH BINDING OF LIGANDS AT THE NQ-BINDING SITE OF THE RESPIRATORY COMPLEX III

SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS

COMPOSITION COMPRISING ALOX5 INHIBITOR FOR PREVENTING OR TREATING SARCOPENIA

sGC STIMULATORS

CYCLIC QUATERNARY AMMONIUM SALT COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF

NOVEL PAR-2 INHIBITORS

ORGANIC COMPOUNDS

Nitrogen-Containing Heterocyclic Compounds

Compositions, Devices, and Methods for Treating or Preventing Headaches

METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND COVID-19

COMPOUND FOR PHOTOOXYGENATION CATALYST AND MEDICINAL COMPOSITION CONTAINING SAME

ACIDIC SALT OR CRYSTAL FORM OF NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF

TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY

DRUG REPURPOSING FOR TREATMENT OF CONGENITAL VASCULAR MALFORMATIONS

GLP-1R MODULATING COMPOUNDS

INHIBITORS OF RLIP76

METHODS OF TREATING NEUROPATHIC PAIN

METHODS AND COMPOSITIONS COMPRISING A SHP2 INHIBITOR AND A PD-LI BINDING ANTAGONIST

TREATMENT OF NEUROLOGICAL DISORDERS

PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS

METHODS TO OVERCOME DRUG RESISTANCE BY RE-SENSITIZING CANCER CELLS TO TREATMENT WITH A PRIOR THERAPY VIA TREATMENT WITH A T CELL THERAPY

COMPOSITIONS COMPRISING METHYLXANTHINES AND DISACCHARIDES DERIVED FROM ENZYMATIC CONVERSION OF SUCROSE

HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS

METHOD FOR TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINE

METHOD FOR TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINE

ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOF

COMBINATION THERAPY

BICYCLIC PIPERAZINONES AND THERAPEUTIC USES THEREOF

BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION

FLUOROQUINOXALINONE DERIVATIVE FOR SELECTIVELY INHIBITING PARP1

REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF

HETEROARYL-SUBSTITUTED BICYCLIC COMPOUND AND USE THEREOF

CRYSTALLINE FORM OF FGFR4 INHIBITOR AND USE THEREOF

PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE

PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS

COMPOUNDS AND METHODS OF USE

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

CDK Inhibitors And Their Use As Pharmaceuticals

COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

COMPOUNDS AS CASEIN KINASE INHIBITORS

DRY EYE TREATMENTS

TRANSMUCOSAL METHODS FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS

BROMOCRIPTINE FORMULATIONS

POLYCYCLIC POLY(ADP-RIBOSE) POLYMERASE SELECTIVE INHIBITOR

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

PHARMACEUTICAL COMPOSITIONS

TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE

NK3 MODULATORS AND USES THEREOF

COMPOUNDS, PREPARATION METHODS AND USES THEREOF

Methods and Compositions for Inhibiting Viral Infection

USE OF TACHYKININ RECEPTOR 3 INHIBITÓR

PHARMACEUTICAL FOR TREATING OR PREVENTING CANCER

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY

GLP-1R Agonist and Therapeutic Method Thereof

TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE

METHODS FOR TREATING HAIR LOSS AND NAIL BRITTLENESS, FRAGILITY, OR PITTING

METHODS OF TREATING OCULAR CONDITIONS

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

PHARMACEUTICAL COMPOSITION FOR PRODUCING SAFE AMOUNT OF NITRIC OXIDE AND USE THEREOF

METHOD OF TREATMENT INCLUDING KRAS G12C INHIBITORS AND AURORA A INHIBITORS

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

ORGANIC COMPOUNDS

COMBINATORIAL, AND ROTATIONAL COMBINATORIAL THERAPIES

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES

TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS

TADALAFIL ORAL SUSPENSION

ARSINOTHRICIN AND METHODS OF TREATING INFECTIONS USING ARSINOTHRICIN

CERTAIN OCTAHYDROFURO[3,4- B]PYRAZINES AS GLP-1 RECEPTOR MODULATORS

FUSED BICYCLIC COMPOUND CONTAINING PYRROLINONE

METHODS OF TREATING OCULAR CONDITIONS

SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF

OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS

PROCESS FOR MAKING A KRAS G12C INHIBITOR

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

TOPICAL ADMINISTRATION TO THE ORAL CAVITY

PHARMACEUTICAL COMPOSITION, USE THEREOF, AND METHOD FOR TREATING CANCER

PIPERAZINO RING-CONTAINING DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

NOVEL HETEROCYCLIC COMPOUND

ISOXAZOLE-HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE

SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF

BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS

STAT6 INHIBITORS AND USES THEREOF

3-PHENYLISOXAZOLE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EYE DISEASE, CONTAINING SAME AS ACTIVE INGREDIENT

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

PRMT5 INHIBITING COMPOUNDS AND USES THEREOF

WRN INHIBITORS

SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS

PULMONARY HYPERTENSION TREATMENT

INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME

ORGANIC COMPOUNDS

USE OF SOS1 INHIBITORS TO TREAT MALIGNANCIES WITH SHP2 MUTATIONS

INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3

NOVEL METHODS

PYRIDONE COMPOUND HAVING INTEGRASE INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF

COMPOUND AND USE THEREOF

SPLEEN TYROSINE KINASE INHIBITOR, COMPOSITION, AND METHODS OF USE

Pharmaceutical Compositions and Methods for Treating Parkinson's Disease

HEXAHYDROPYRIDO[4,3-B]INDOLYL KETONE DERIVATIVES USEFUL AS CGAS MODULATORS

CYCLOALKYL OR HETEROCYCLYL SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND USE THEREOF

G ALPHA Q/11 INHIBITORS FOR USE AS AN ANALGESIC

INHIBITOR OF INTERACTION BETWEEN YAP/TAZ AND TEAD, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF

METHOD OF TREATMENT INCLUDING KRAS G12C INHIBITORS AND SHP2 INHIBITORS

BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same

2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME

WRN INHIBITORS

WRN INHIBITORS

WRN INHIBITORS

RE-SENSITIZING MULTIDRUG-RESISTANT (MDR) GRAM-NEGATIVE BACTERIA TO COLISTIN USING IONOPHORES

METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASES

MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3,-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

NUCLEOBASE-SUBSTITUTED PIPERIDINYL-PYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING DISEASES AND CONDITIONS

EXTENDED RELEASE UPADACITINIB FORMULATIONS

COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING OBESITY AND DIABETES COMPRISING ZINC GLUCONATE AND CYCLO-HISPRO AS ACTIVE INGREDIENTS

CBL-B INHIBITOR, COMPOSITIONS COMPRISING A CBL-B INHIBITOR IN A METHOD OF TREATING A DISEASE ASSOCIATED WITH CELL PROLIFERATION

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

COMPOUNDS AND METHODS FOR MODULATING SPLICING

PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING ACTIVE INGREDIENT COMPOUND THEREOF

MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF

3,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof

POLYCYCLIC COMPOUND AND USE THEREOF

SUBLINGUAL COMPOSITIONS FOR ERECTILE DYSFUNCTION

KHK INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF

THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF

INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF

SITAGLIPTIN PREPARATION AND METHOD OF STORAGE THEREOF

ADRM1/RPN13 SPLICED VARIANT IN THE PROGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA

PAD4 INHIBITORS AND USE THEREOF

CYCLOPIPERIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF

MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF

SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

HETEROCYCLIC DERIVATIVES AS MALT1 INHIBITORS

FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS

PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF

COMPOSITIONS AND METHODS RELATING TO ATP/P2X7R SIGNALING INHIBITION